...
首页> 外文期刊>Liver international : >Rogal, S.S.a , Winger, D.b , Bielefeldt, K.a , Rollman, B.L.c , Szigethy, E.d Healthcare utilization in chronic liver disease: The importance of pain and prescription opioid use
【24h】

Rogal, S.S.a , Winger, D.b , Bielefeldt, K.a , Rollman, B.L.c , Szigethy, E.d Healthcare utilization in chronic liver disease: The importance of pain and prescription opioid use

机译:Rogal,S.S.a,Winger,D.b,Bielefeldt,K.a,Rollman,B.L.c,Szigethy,E.d慢性肝病中的医疗保健利用:疼痛和处方阿片类药物的重要性

获取原文
获取原文并翻译 | 示例

摘要

Background & Aims: The aim of this study was to assess factors associated with healthcare utilization in patients with chronic liver disease with a focus on pain, opioid use and psychiatric symptoms. Methods: We retrospectively assessed a consecutive sample of 1286 visitors to a hepatology clinic with chronic liver disease. Baseline psychiatric symptoms, pain and opioid prescriptions were collected. Liver-related clinic visits, total clinic visits, phone calls and hospitalizations were assessed over a subsequent 6-month period. Multivariable logistic and negative binomial regression models were used to determine the medical and psychosocial factors associated with increased healthcare utilization. Results: Over a 6-month period, hospitalization was more common among patients with pain (13% vs. 7%, P < 0.0001) and opioid usage (18% vs. 6% P < 0.0001). Pain and opioid usage were independently and significantly associated with an increased hospitalizations and median number of clinic visits and phone calls (P < 0.0001). In multivariable modelling, hospitalization was significantly associated with opioid use (OR = 2.72, CI = 1.72, 4.29), Child's Class B (OR = 2.24, CI = 1.19, 4.14) and C (OR = 8.51, CI = 4.18, 17.27) cirrhosis, and cardiopulmonary disease (OR = 2.11, CI = 1.28, 3.41). Pain and opioid usage were independently and significantly associated with the numbers of phone calls and total outpatient visits, as were medical comorbidities and Child's Class. The significant predictors of increased outpatient liver-related visits were pain (IRR = 1.13, CI = 1.02, 1.26), interferon usage (IRR = 1.75, CI = 1.54, 1.98) and more advanced liver disease (IRR = 1.58, CI = 1.32, 1.88). Conclusions: Pain and prescription opioid usage were significantly linked to increased healthcare utilization, suggesting the need to evaluate and incorporate evidence-based pain management strategies into routine care of patients with chronic liver disease.
机译:背景与目的:这项研究的目的是评估与慢性肝病患者的医疗保健利用相关的因素,重点是疼痛,阿片类药物的使用和精神病症状。方法:我们回顾性评估了连续1286位来访者的慢性肝病肝病门诊样本。收集基线精神症状,疼痛和阿片类药物处方。在随后的6个月中评估了与肝脏有关的诊所就诊,总诊所就诊,电话和住院情况。使用多变量logistic和负二项式回归模型来确定与医疗保健利用率增加相关的医学和社会心理因素。结果:在六个月的时间里,疼痛和阿片类药物使用(分别为18%和6%,P <0.0001)的患者(13%比7%,P <0.0001)更常见。疼痛和阿片类药物的使用独立且显着地与住院次数的增加以及诊所就诊和电话的中位数有关(P <0.0001)。在多变量建模中,住院与阿片类药物使用显着相关(OR = 2.72,CI = 1.72,4.29),儿童B类(OR = 2.24,CI = 1.19,4.14)和C(OR = 8.51,CI = 4.18,17.27)肝硬化和心肺疾病(OR = 2.11,CI = 1.28,3.41)。疼痛和阿片类药物的使用与电话次数和门诊总次数独立且显着相关,医疗合并症和儿童病也是如此。门诊肝脏相关就诊增加的重要预测因素是疼痛(IRR = 1.13,CI = 1.02,1.26),干扰素使用(IRR = 1.75,CI = 1.54,1.98)和更晚期的肝病(IRR = 1.58,CI = 1.32) ,1.88)。结论:疼痛和处方阿片类药物的使用与医疗保健利用率的提高密切相关,这表明需要评估并将循证性疼痛管理策略纳入慢性肝病患者的常规护理。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号